Skip to main content
SBRA logo

SBRA · Sabra Health Care REIT, Inc.

Track SBRA — free
Market Cap
$5.30B
Shares
255.46M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$20.61 Open$20.77 Day$20.56–20.82 52W close$17.23–22.39 Avg vol 30d2.7M Short int24.7M · 9.7% float · 8.7d Short vol74% Last earningsAug 4, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 3

Up next

Next earnings call
Nov 7, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 3, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol Low
      Market backdrop VIX 14.4 · calm Equity put/call 0.39
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +4%
      above
      Price vs 50-day avg +1%
      above
      RSI (14) 50
      neutral
      MACD trend Positive
      52-week position 66%
      mid-range
      Volume (OBV) Bullish div.
      accumulating
      Momentum
      relative strength
      Weak
      1-month return −3%
      trailing
      6-month return 0%
      trailing
      YTD return +9%
      this year
      Relative strength −14%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $20 › 200d $20 — 50d above 200d
      Institutional flow Accumulating
      +0% holders QoQ · +54 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      9.67% of float · ▲ +0.6% MoM · 8.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      464 holders — near 3-yr high, broad support
      Squeeze score 69
      elevated · 0–100
      Fundamentals
      Fair
      Revenue growth +10%
      Y/Y
      EPS growth +19%
      Y/Y
      Valuation P/E 79.8
      rich
      Balance sheet $2.5B
      net debt
      Quant / Vol
      risk profile
      Low
      Volatility 24%
      annualized · 1-yr
      Max drawdown −17%
      past year
      ATR 2.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Feb 12, 2026
      Net Income · 2026 $0.60 – $0.64
      FFO · 2026 $1.49 – $1.53
      Normalized FFO · 2026 $1.49 – $1.53
      AFFO · 2026 $1.55 – $1.59
      Normalized AFFO · 2026 $1.55 – $1.59
      Prior guidance period ended · from the 8-K filed Nov 5, 2025
      Net Income · 2025 $0.66 – $0.67
      FFO · 2025 $1.47 – $1.48
      Normalized FFO · 2025 $1.46 – $1.47
      AFFO · 2025 $1.46 – $1.47
      Normalized AFFO · 2025 $1.50 – $1.51

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 3 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +4% Bullish
      Price vs 50-day avg
      +1% Bullish
      RSI (14)
      50 Neutral
      MACD trend
      Positive Bullish
      52-week position
      66% Neutral
      Volume (OBV)
      Bullish div. Bullish
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $20 › 200d $20 — 50d above 200d
      Institutional flow Accumulating
      +0% holders QoQ · +54 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      9.67% of float · ▲ +0.6% MoM · 8.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      464 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $17 Now $21 · 66% Range high $22
      vs 200-day avg +4% vs 50-day avg +1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Beds/units 37,043 as of June 30, 2026
      Behavioral health facilities 16 as of June 30, 2026
      Cash NOI (Same Store) non-GAAP $28.56M Three Months Ended June 30, 2026
      Cash NOI - Consolidated Senior Housing - Managed non-GAAP $40.07M Three Months Ended June 30, 2026
      Consolidated Enterprise Value $7.9B As of June 30, 2026
      Cost of Permanent Consolidated Debt non-GAAP 3.92% As of June 30, 2026
      Debt as a % of Asset Value 37% As of June 30, 2026
      Interest savings from hedged variable rate exposure $7M last 12 months
      Investments 395 As of June 30, 2026
      Investments in loans receivable 11 as of June 30, 2026
      Liquidity $1.3B As of June 30, 2026
      Real estate properties held for investment 364 as of June 30, 2026
      Relationships 61 As of June 30, 2026
      Senior housing - leased communities 32 as of June 30, 2026
      Senior housing - managed communities 94 as of June 30, 2026
      Skilled Mix 39% As of June 30, 2026
      Skilled nursing/transitional care facilities 207 as of June 30, 2026
      Specialty hospitals and other facilities 15 as of June 30, 2026
      Unencumbered Assets/Unsecured Debt non-GAAP 265% As of June 30, 2026
      Weighted average effective interest rate on permanent debt 3.92% As of June 30, 2026
      Weighted average number of common shares outstanding, diluted - AFFO and Normalized AFFO non-GAAP 256,733,670 Three Months Ended June 30, 2026
      Weighted average number of common shares outstanding, diluted - Normalized FFO non-GAAP 255,912,180 Three Months Ended June 30, 2026
      Workforce diversity - ethnic minorities self-identified 34% As of June 30, 2026
      Workforce diversity - women in management/leadership roles 58% As of June 30, 2026
      Workforce diversity - women in workforce 55% As of June 30, 2026
      Wtd. Avg. Remaining Lease Term 7 As of June 30, 2026
      Annualized Cash Net Operating Income - pro rata non-GAAP $543.39M Q1 FY2026
      GAAP → non-GAAP reconciliation
      GAAP Cash Net Operating Income - pro rata 138.68M
      +404.71M Annualizing adjustments
      = Annualized Cash Net Operating Income - pro rata 543.39M
      Annualized Cash Net Operating Income, as adjusted - pro rata non-GAAP $543.39M Q1 FY2026
      Available borrowings under revolving credit facility $645M first quarter of 2026
      GAAP → non-GAAP reconciliation
      GAAP Net Operating Income - pro rata $38.98M
      +$4K Non-cash revenue and expense adjustments
      = Cash Net Operating Income - pro rata $38.98M
      Cash NOI - Same Store Senior Housing - Managed non-GAAP $23.5M Three Months Ended March 31, 2026
      Cash NOI - Senior Housing - Managed Consolidated Portfolio non-GAAP $34.72M Three Months Ended March 31, 2026
      Cash NOI Margin % - Senior Housing - Managed Consolidated Portfolio non-GAAP 29.8% Three Months Ended March 31, 2026
      Common shares outstanding 252.2M As of March 31, 2026
      Common stock closing price $19.23 As of March 31, 2026
      Net operating income $140.27M Three Months Ended March 31, 2026
      Net Operating Income - pro rata $140.27M Q1 FY2026
      GAAP → non-GAAP reconciliation
      GAAP Net Operating Income - consolidated $39.08M
      -$99K Net Operating Income attributable to noncontrolling interests
      = Net Operating Income - pro rata $38.98M
      Number of Properties - Senior Housing - Managed Consolidated Portfolio 90 Three Months Ended March 31, 2026
      Number of Units - Senior Housing - Managed Consolidated Portfolio 9,078 Three Months Ended March 31, 2026
      Occupancy - Senior Housing - Managed Consolidated Portfolio 84.5% Three Months Ended March 31, 2026
      Property Count - Consolidated Real Estate Investments 361 As of March 31, 2026
      Property Count - Total Equity Investments 377 As of March 31, 2026
      Property Count - Total Investments 395 As of March 31, 2026
      Property Count - Total Triple-Net Portfolio 271 As of March 31, 2026
      Quarterly cash dividend per share $0.3 first quarter of 2026
      REVPOR - Same Store Senior Housing - Managed non-GAAP $4,755 Three Months Ended March 31, 2026
      Same property managed senior housing Cash NOI non-GAAP 14.4% first quarter of 2026
      Shares remaining outstanding under forward sale agreements 23.7M first quarter of 2026
      Adjusted EBITDA non-GAAP 121.23M Three Months Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP EBITDA 107.98M
      -1.65M Income from unconsolidated joint ventures
      +2.16M Distributions from unconsolidated joint ventures
      +3.07M Stock-based compensation expense
      +453K Acquisition and transaction costs
      -407K Recovery of loan losses
      +648K Impairment of real estate
      -91K Other income
      +9.06M Net loss on sales of real estate
      = Adjusted EBITDA 121.23M
      Adjusted EBITDA, as adjusted non-GAAP 123.9M Three Months Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP Adjusted EBITDA 121.23M
      +2.68M Adjustments for current period activity
      = Adjusted EBITDA, as adjusted 123.9M
      Adjusted EBITDA, as adjusted, annualized non-GAAP 495.61M Three Months Ended December 31, 2025
      AFFO attributable to Sabra Health Care REIT, Inc. non-GAAP 361.57M Year Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP FFO attributable to Sabra Health Care REIT, Inc. 360.87M
      +11.36M Stock-based compensation expense
      -1.02M Non-cash rental and related revenues
      +7.97M Non-cash interest expense
      -1.73M Non-cash portion of loss on extinguishment of debt
      -1.05M Recovery of loan losses
      +313K Other adjustments related to unconsolidated joint ventures
      -15.14M Other adjustments
      = AFFO attributable to Sabra Health Care REIT, Inc. 361.57M
      Ample liquidity $1.2B current
      Availability under at-the-market equity offering program $482.9M current
      Borrowings unsecured 98% current
      Cash NOI non-GAAP $23.14M Q4 FY2025
      Consolidated Portfolio Number of Properties 87 Three Months Ended December 31, 2025
      Consolidated Portfolio Number of Units 8,677 Three Months Ended December 31, 2025
      Consolidated Portfolio Occupancy 84.8% Three Months Ended December 31, 2025
      Consolidated Real Estate Investments Beds/Units 36,412 December 31, 2025
      Consolidated Real Estate Investments Total 360 December 31, 2025
      FFO attributable to Sabra Health Care REIT, Inc. non-GAAP 360.87M Year Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP Net income attributable to Sabra Health Care REIT, Inc. 155.61M
      +187M Depreciation and amortization of real estate assets
      -163K Depreciation and amortization of real estate assets related to noncontrolling interests
      +7.58M Depreciation and amortization of real estate assets related to unconsolidated joint ventures
      +3.52M Net loss (gain) on sales of real estate
      +7.32M Impairment of real estate
      = FFO attributable to Sabra Health Care REIT, Inc. 360.87M
      Interest savings $7.9M last 12 months
      Net Debt non-GAAP 2.48B December 31, 2025
      Net Operating Income - consolidated non-GAAP 518.54M Year Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP Net income 155.51M
      +187M Depreciation and amortization
      +112.49M Interest
      +53.71M General and administrative
      -1.05M Recovery of loan losses
      +7.32M Impairment of real estate
      +1.15M Loss on extinguishment of debt
      -14.04M Other income
      +3.52M Net (gain) loss on sales of real estate
      -3.93M Income from unconsolidated joint ventures
      +1.84M Income tax expense
      +15.01M Sabra's share of unconsolidated joint ventures' Net Operating Income
      = Net Operating Income - consolidated 518.54M
      Normalized AFFO attributable to Sabra Health Care REIT, Inc. non-GAAP 365.41M Year Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP AFFO attributable to Sabra Health Care REIT, Inc. 361.57M
      -1.52M Lease termination income, net of expense
      +2.88M Cash portion of loss on extinguishment of debt
      +0K Write-off of cash rental income
      +2.47M Other normalizing items
      = Normalized AFFO attributable to Sabra Health Care REIT, Inc. 365.41M
      Normalized FFO attributable to Sabra Health Care REIT, Inc. non-GAAP 352.91M Year Ended December 31, 2025
      GAAP → non-GAAP reconciliation
      GAAP FFO attributable to Sabra Health Care REIT, Inc. $360.87M
      +$7.76M Write-offs of cash and straight-line rental income receivable and lease intangibles
      -$1.52M Lease termination income, net of expense
      +$1.15M Loss on extinguishment of debt
      -$1.05M Recovery of loan losses
      -$14.3M Other normalizing items
      = Normalized FFO attributable to Sabra Health Care REIT, Inc. $352.91M
      Number of Available Units 6,194 Q4 FY2025
      Number of Investments 4 December 31, 2025
      Number of Loans 13 December 31, 2025
      Number of Properties 68 Q4 FY2025
      REVPOR $4,506 Three Months Ended December 31, 2025
      Same store Cash Net Operating Income - pro rata non-GAAP 23.14M Three Months Ended December 31, 2025
      Same Store Operating Performance Number of Available Units 6,194 Three Months Ended December 31, 2025
      Same Store Operating Performance Number of Properties 68 Three Months Ended December 31, 2025
      Secured Debt as a % of Asset Value 1% current
      SNF concentration 35% current
      Top five relationships concentration 48% current
      Total Debt/Asset Value non-GAAP 37% December 31, 2025
      Total Equity Investments 376 December 31, 2025
      Total Investments 393 December 31, 2025
      Unconsolidated Portfolio Number of Properties 16 Three Months Ended December 31, 2025
      Unconsolidated Portfolio Number of Units 1,256 Three Months Ended December 31, 2025
      Unconsolidated Portfolio Occupancy 93.5% Three Months Ended December 31, 2025
      Weighted average debt maturity 4 current

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      SBRA
      Sabra Health Care REIT, Inc.
      this stock
      $5.30B +8.8% +10.2% 79.8 9.7%
      WELL
      Welltower Inc.
      $168.06B +28.3% +35.6% 118.4 2.5%
      VTR
      Ventas, Inc.
      $47.09B +18.6% +18.5% 170.0 4.6%
      DOC
      Healthpeak Properties, Inc.
      $14.66B +30.3% +4.5% 60.7 3.3%
      OHI
      Omega Healthcare Investors Inc
      $14.03B +3.7% +13.2% 16.5 4.0%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      464
      % held
      102.0%
      Net QoQ
      +1.9M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      438
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      24.7M
      Days to cover
      8.7d
      Change
      +157.6K sh
      View
      Short Volume
      Short vol %
      74%
      As of
      Aug 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      179
      Value
      $3.5K
      As of
      Jul 16, 2026
      View
      Off-Exchange
      Off-exchange %
      39.1%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Apr 10, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $774.6M
      Net income (FY)
      $155.6M
      EPS diluted
      $0.64
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 3, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $192.5K
      Shares
      11.0K
      Filed
      May 15, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 4, 2026
      View
      Investor Relations
      Latest news
      Sabra Reports Second Quarter 2026…
      Published
      Aug 3, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      SBRA +1.1% -2.7% -0.1% -2.7% +8.8%
      SPY +0.5% +3.0% +13.4% +3.0% +12.8%
      vs SPY +0.6% -5.6% -13.5% -5.6% -4.0%

      Capital returns

      Latest dividend
      $0.30 / share · ex Aug 14, 2026
      Cut 33.3%
      Paid (TTM)
      $1.20 / share · 4 payouts
      Dividend yield (TTM, derived)
      5.82%

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1492298 CUSIP 78573L106 13F (30d) 349 filings 345 filers Visit website Investor relations